PTGS2 and depressive disorder: In addition, the genetic effects of COX2 and PLA2 as well the therapeutic effects of n-3 PUFAs on specific symptoms, for example, depressive symptoms in CVD or somatic symptoms, such as HRV, chest tightness, dyspnea, somatic pain symptoms in depression, are also very important to support our hypothesis.